Nariman Nassiri is an Ophthalmology physician affiliated with University of California, Los Angeles. OpenAlex indexes 106 publications with 1,663 citations (h-index 23); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
625 S Fair Oaks Ave
Pasadena, CA 911052613
Telephone
626-817-4747Provider last certified this registry record 16 Jan 2025.
Clinical trials
1 registered study on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year202519 payments
- Bausch & Lomb Americas Inc.Program year20252 payments
- Glaukos CorporationProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
78.3%Prostaglandin Analog32.9%Latanoprost86%Lumigan12%Travoprost2%Iyuzeh1%Part D<11 patientsCarbonic Anhydrase Inhibitor19%Dorzolamide-Timolol69%Dorzolamide Hcl15%Acetazolamide7%Simbrinza4%Brinzolamide3%Cosopt Pf1%Part D<11 patients+ 8 more classes in this area
Cardiovascular
10.8%Beta blocker10.8%Timolol Maleate100%Part D≥194 patientsAnti-infectives
3.9%Macrolide2.3%Erythromycin100%Part D≥100 patientsFluoroquinolone Antibacterial1.4%Moxifloxacin100%Part D≥57 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Metabolomic Profiling of Aqueous Humor From Glaucoma Patients Identifies Metabolites With Anti-Inflammatory and Neuroprotective Potential in Mice
Investigative Ophthalmology & Visual Science
2025 - Three-year outcomes of trabeculectomy and Ahmed valve implant in patients with prior failed filtering surgeries
International Ophthalmology
2020 - Factors Associated with the Development of Posterior Capsule Opacification Requiring Yttrium Aluminum Garnet Capsulotomy
Optometry and Vision Science
2019 - Factors associated with conjunctival erosions after ahmed glaucoma valve implantation
Journal of Ophthalmic and Vision Research
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Dennis Slamon, MD
University of California, Los Angeles
Beth Karlan, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
Robert Modlin, MD
University of California, Los Angeles
Emily Chew, MD
National Eye Institute
Robert Weinreb, MD
University of California San Diego
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”